Akero Therapeutics

Yahoo Finance • 11 hours ago

Notable healthcare headlines for the week: Novo Nordisk, Bristol Myers Squibb and J&J in focus

Tom Werner Wall Street's major averages plummeted on Friday after U.S. President Donald Trump threatened higher tariffs to China, saying it had "become very hostile" sending letters to other countries wanting to "impose export controls."... Full story

Yahoo Finance • 14 hours ago

Key deals this week: Protagonist Therapeutics, Bristol Myers, Novo Nordisk, Fifth Third Bancorp and more

Here's a list of key deals reported across sectors this week: * Protagonist Therapeutics (NASDAQ:PTGX [https://seekingalpha.com/symbol/PTGX]), a biotech focused on peptide-based therapeutics, traded ~30% higher on Friday after The Wall... Full story

Yahoo Finance • yesterday

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Akero Therapeutics, Inc. (NASDAQ: AKRO)

NEW YORK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in th... Full story

Yahoo Finance • 2 days ago

Akero Therapeutics (AKRO) Jumps 16% on $5.2-Billion Novo Nordisk Merger

We recently published 10 Big Names With Whopping Gains; 6 Jump All-Time Highs. Akero Therapeutics, Inc. (NASDAQ:AKRO) is one of the best performers on Thursday. Akero Therapeutics saw its share prices jump by 16.33 percent on Thursday to... Full story

Yahoo Finance • 2 days ago

Stocks Falter as Higher Bond Yields Spark Long Liquidation

The S&P 500 Index ($SPX) (SPY) on Thursday closed down -0.28%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.52%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.15%.  December E-mini S&P futures (ESZ25) fell -0.30%, a... Full story

Yahoo Finance • 3 days ago

Noteworthy Thursday Option Activity: AKRO, DHI, AFRM

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Akero Therapeutics Inc (Symbol: AKRO), where a total of 8,313 contracts have traded so far, representing approximately 831,300 und... Full story

Yahoo Finance • 3 days ago

Stocks Fall on Higher Bond Yields and Weakness in Chipmakers

The S&P 500 Index ($SPX) (SPY) today is down -0.24%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.36%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.32%.  December E-mini S&P futures (ESZ25) are down -0.26%, and December E-... Full story

Yahoo Finance • 3 days ago

Stocks making the biggest moves midday: Oracle, Ferrari, Delta, Albemarle and more

Check out the companies making the biggest moves in midday trading: Oracle — Shares of the software company rose more than 3% on Thursday after Baird initiated coverage with a outperform rating and a $365 price taget. The firm said Oracle... Full story

Yahoo Finance • 3 days ago

Top Stock Movers Now: Delta Air Lines, PepsiCo, Akero Therapeutics, and More

Joan Valls / Urbanandsport / NurPhoto via Getty Images Shares of Delta Air Lines surged after the carrier posted better-than-expected results and issued a rosy current-quarter outlook Key Takeaways Major U.S. equities indexes pulled back... Full story

Yahoo Finance • 3 days ago

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates AKRO, CCRD, AL, PBBK on Behalf of Shareholders

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 3 days ago

Novo Nordisk to Buy Akero Therapeutics in $5.2 Billion Deal

Novo Nordisk (NVO) agreed to acquire Akero Therapeutics (AKRO) for up to $5.2 billion as the Danish PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 3 days ago

Market Chatter: Novo Nordisk CEO Poised to Take Risks in Weight-Loss Rivalry

Novo Nordisk (NVO) Chief Executive Officer Mike Doustdar said he is poised to face calculated risks PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 3 days ago

Viking Therapeutics, Genfit, Sagimet jump as Novo to buy Akero

Viking Therapeutics (NASDAQ:VKTX [https://seekingalpha.com/symbol/VKTX]) and other biotechs advancing drugs for a liver disease called metabolic dysfunction-associated steatohepatitis (MASH) gained on Thursday as the MASH space witnessed t... Full story

Yahoo Finance • 3 days ago

Novo to buy Akero for up to $5.2 billion in new CEO's revival push

By Maggie Fick and Mariam Sunny (Reuters) -Novo Nordisk said on Thursday it would buy U.S.-based Akero Therapeutics for up to $5.2 billion to gain access to a promising liver disease drug candidate, in the first major deal by the Danish d... Full story

Yahoo Finance • 3 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD), PB Bankshares, Inc. (Nasdaq - PBBK), Air Lease Corporation (NYSE - AL)

BALA CYNWYD, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • 3 days ago

Stocks Pressured by Higher Bond Yields

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is down -0.07%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futures... Full story

Yahoo Finance • 3 days ago

Novo Nordisk Bulks Up Its Obesity-Tied Portfolio With $4.7 Billion Buyout

Novo Nordisk said Thursday it will pay $4.7 billion up front to acquire Akero Therapeutics for its experimental liver disease treatment. Continue Reading View Comments... Full story

Yahoo Finance • 3 days ago

Stocks making the biggest moves premarket: Ferrari, PepsiCo, Delta, Akero Therapeutics and more

Check out the companies making the biggest moves in premarket trading: Ferrari — The luxury carmaker tumbled nearly 14% after it trimmed its electrification targets . Ferrari said it expects its 2030 sports car model line-up to be made up... Full story

Yahoo Finance • 3 days ago

Akero Therapeutics Stock Soars. Novo Nordisk Is Buying the Biotech for Up to $5.2 Billion.

Novo said it would buy Akero for $54 a share in cash and an additional $6 if it gets U.S. approval of Efruxifermin - it’s treatment for fatty liver disease. Continue Reading 查看留言... Full story

Yahoo Finance • 3 days ago

Novo Nordisk To Buy Akero Therapeutics for $4.7 Billion

Akero shareholders will receive $54 per share initially, plus $6 per share contingent on U.S. regulatory approval of its EFX drug. Continue Reading View Comments... Full story